Clinical Trial Update: Registry For Patients Treated With BeneFix In Usual Care Setting In Germany

View source ↗

Summary

A registry trial update for BeneFix in the usual care setting in Germany for Hemophilia B, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• BeneFIX (recombinant coagulation factor IX concentrate)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia B | Status: COMPLETED | Results posted: 2018-09-24